← Back to Screener
Axogen, Inc. Common Stock (AXGN)
Price$37.23
Favorite Metrics
Price vs S&P 500 (26W)132.03%
Price vs S&P 500 (4W)15.59%
Market Capitalization$2.00B
All Metrics
P/CF (Annual)2468.97x
Book Value / Share (Quarterly)$2.73
P/TBV (Annual)12.36x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)17.56%
Cash Flow / Share (Quarterly)$-0.10
Price vs S&P 500 (YTD)13.49%
Gross Margin (TTM)74.31%
Net Profit Margin (TTM)-6.97%
EPS (TTM)$-0.34
10-Day Avg Trading Volume1.28M
EPS Excl Extra (TTM)$-0.34
Revenue Growth (5Y)14.93%
EPS (Annual)$-0.34
ROI (Annual)-8.86%
Gross Margin (Annual)74.31%
Net Profit Margin (5Y Avg)-13.60%
Cash / Share (Quarterly)$0.88
Revenue Growth QoQ (YoY)21.25%
ROA (Last FY)-7.08%
Revenue Growth TTM (YoY)20.21%
EBITD / Share (TTM)$-0.02
ROE (5Y Avg)-19.41%
Operating Margin (TTM)-3.49%
Cash Flow / Share (Annual)$-0.10
P/B Ratio15.56x
P/B Ratio (Quarterly)11.72x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)8.96x
Net Interest Coverage (TTM)-0.96x
ROA (TTM)-7.48%
EV / EBITDA (TTM)207.05x
EPS Incl Extra (Annual)$-0.34
Current Ratio (Annual)5.11x
Quick Ratio (Quarterly)3.04x
3-Month Avg Trading Volume0.98M
52-Week Price Return147.11%
EV / Free Cash Flow (Annual)152711.73x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.59
P/S Ratio (Annual)8.90x
Asset Turnover (Annual)1.02x
52-Week High$39.99
Operating Margin (5Y Avg)-12.02%
EPS Excl Extra (Annual)$-0.34
CapEx CAGR (5Y)-24.37%
Tangible BV CAGR (5Y)0.16%
26-Week Price Return140.78%
Quick Ratio (Annual)3.04x
13-Week Price Return25.00%
Total Debt / Equity (Annual)0.38x
Current Ratio (Quarterly)5.11x
Enterprise Value$2,017.697
Revenue / Share Growth (5Y)11.74%
Asset Turnover (TTM)1.07x
Book Value / Share Growth (5Y)-2.09%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.53x
Pretax Margin (Annual)-6.97%
Cash / Share (Annual)$0.88
3-Month Return Std Dev52.53%
Gross Margin (5Y Avg)77.74%
Net Income / Employee (TTM)$-0
ROE (Last FY)-12.19%
Net Interest Coverage (Annual)-0.96x
EPS Basic Excl Extra (Annual)$-0.34
P/FCF (TTM)221.33x
Receivables Turnover (TTM)8.96x
EV / Free Cash Flow (TTM)815.45x
Total Debt / Equity (Quarterly)0.38x
EPS Incl Extra (TTM)$-0.34
Receivables Turnover (Annual)8.96x
ROI (TTM)-9.52%
P/S Ratio (TTM)8.90x
Pretax Margin (5Y Avg)-13.60%
Revenue / Share (Annual)$4.89
Tangible BV / Share (Annual)$2.59
Forward P/E70.69x
Price vs S&P 500 (52W)112.02%
Year-to-Date Return17.63%
5-Day Price Return15.03%
EPS Normalized (Annual)$-0.34
ROA (5Y Avg)-10.15%
Net Profit Margin (Annual)-6.97%
Month-to-Date Return16.21%
Cash Flow / Share (TTM)$-0.46
EBITD / Share (Annual)$-0.02
Operating Margin (Annual)-3.49%
LT Debt / Equity (Annual)0.38x
P/CF (TTM)2468.97x
ROI (5Y Avg)-13.51%
LT Debt / Equity (Quarterly)0.38x
EPS Basic Excl Extra (TTM)$-0.34
P/TBV (Quarterly)12.36x
P/B Ratio (Annual)11.72x
Inventory Turnover (TTM)1.53x
Pretax Margin (TTM)-6.97%
Book Value / Share (Annual)$2.73
Price vs S&P 500 (13W)22.13%
Beta1.08x
P/FCF (Annual)182255.23x
Revenue / Share (TTM)$4.84
ROE (TTM)-13.44%
52-Week Low$9.22
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.19
4.19
4.18
4.19
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
AXGNAxogen, Inc. Common Stock | 8.90x | 14.93% | 74.31% | -3.49% | $37.23 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.00 |
MASIMasimo Corporation | 6.11x | 5.95% | 61.90% | 20.30% | $178.45 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $113.13 |
LIVNLivaNova PLC Ordinary Shares | 2.59x | 8.24% | 68.04% | 14.09% | $65.81 |
ITGRInteger Holdings Corporation | 1.66x | 11.55% | 27.39% | 11.90% | $89.32 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.68 |
BLFSBioLife Solutions Inc. | 10.84x | 14.87% | 64.56% | -17.26% | $22.19 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.57 |
CBLLCeriBell, Inc. Common Stock | 8.96x | — | 87.89% | -65.57% | $21.13 |
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
About
Axogen commercializes regenerative medicine solutions for peripheral nerve repair, including grafts, connectors, and protective devices sold in the US, Canada, Europe, and select international markets. The company serves orthopedic and trauma surgeons with clinically validated products designed to improve surgical outcomes. Its portfolio includes Avance Nerve Graft, Axoguard connectors and protectors, and diagnostic assessment tools.